Study of Dasatinib and Docetaxel in Metastatic Hormone Refractory Prostate Cancer
Clinical trial NCT00439270 · COMPLETED
Trial details
- NCT number
- NCT00439270
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2012-02-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.